6 research outputs found

    Drugs consumptions in the six months before acute HCV infection diagnosis in the 53 HIV-infected MSM with self-administered questionnaire, HEPAIG study, 2006–2007.

    No full text
    <p>Note. Data are no. (%) of patients. MDA, 3–4 methylene dioxy-amphetamine; GHB, gamma hydroxy butyric acid; <sup>a</sup>including anxiolytic, hypnotic or antidepressant; <sup>b</sup>several possible answers; <sup>c</sup>use at least 10 times during the six-month period</p

    Main characteristics of the 80 HIV-infected MSM at acute HCV infection diagnosis reported by physicians, medical questionnaire, HEPAIG study, 2006–2007.

    No full text
    <p>Note. Data are no. (%) of patients or median values (inter-quartile range); MSM, men who have sex with men; HAART, highly active antiretroviral treatment; STI, sexually transmitted infection; ALT, alanine aminotransferase; ULN, upper limit of normal; <sup>a</sup><50 copies/mL; <sup>b</sup>several possible answers; <sup>c</sup>anti-HCV (+) within one year after anti-HCV (-) or HCV RNA (+) within one year after both documented anti-HCV (-) and HCV RNA (-); <sup>d</sup>HCV RNA (+) either: i) within one year after two documented HCV RNA (-), or, ii) with symptoms of acute hepatitis and ALT level >10xULN within one year after regular controls of normal ALT (other causes excluded); <sup>e</sup>possible acute HCV infection following primary infection with confirmed viral clearance.</p
    corecore